Search Ontology:
ChEBI
N-{(1S)-2-{4-[(5R)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl}-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]ethyl}-2,2,2-trifluoroacetamide
- Term ID
- CHEBI:43531
- Synonyms
-
- N-{(1S)-2-{4-[(5R)-1,1-dioxido-3-oxoisothiazolidin-5-yl]phenyl}-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]ethyl}-2,2,2-trifluoroacetamide
- N-{(1S)-2-{4-[(5S)-1,1-dioxido-3-oxoisothiazolidin-5-yl]phenyl}-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]ethyl}-2,2,2-trifluoroacetamide
- Definition
- References
-
- pdb-ccd:IZE
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from N-{(1S)-2-{4-[(5R)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl}-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]ethyl}-2,2,2-trifluoroacetamide
Phenotype where environments contain N-{(1S)-2-{4-[(5R)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl}-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]ethyl}-2,2,2-trifluoroacetamide
Phenotype modified by environments containing N-{(1S)-2-{4-[(5R)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl}-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]ethyl}-2,2,2-trifluoroacetamide
Phenotype affecting N-{(1S)-2-{4-[(5R)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl}-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]ethyl}-2,2,2-trifluoroacetamide
Human Disease Model